SCHEMBL8965244

SCHEMBL8965244

COc1ccc(C(=O)c2ccc(Oc3ccccc3)cc2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRD5A2 P31213 4/20 0.72
▸ LTA4H P09960 1/20 0.69
▸ CES2 O00748 1/20 0.63
▸ CES1 P23141 1/20 0.63
▸ PARP10 Q53GL7 2/20 0.61
▸ KMT2A Q03164 2/20 0.61
▸ MEN1 O00255 1/20 0.61
▸ LMNA P02545 1/20 0.61
▸ MAPT P10636 1/20 0.61
▸ MAPK1 P28482 1/20 0.61
▸ RAB9A P51151 1/20 0.61
▸ NPSR1 Q6W5P4 1/20 0.61
▸ RXFP1 Q9HBX9 1/20 0.61
▸ HPGD P15428 1/20 0.61
▸ ACHE P22303 1/20 0.59
▸ CA1 P00915 1/20 0.59
▸ CA2 P00918 1/20 0.59
▸ ELANE P08246 1/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ GAA P10253 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18656383 1.00 SRD5A2 (0.72) SRD5A2LTA4HCES2CES1PARP10
SCHEMBL6426895 0.96 CES2 (0.69) SRD5A2LTA4HCES2CES1PARP10
SCHEMBL27399130 0.92 PARP10 (0.70) SRD5A2LTA4HCES2CES1PARP10
SCHEMBL19008823 0.92 PARP10 (0.70) SRD5A2LTA4HCES2CES1PARP10
SCHEMBL19008826 0.92 PARP10 (0.70) SRD5A2LTA4HCES2CES1PARP10
SCHEMBL24538828 0.92 PARP10 (0.70) SRD5A2LTA4HCES2CES1PARP10
SCHEMBL10494485 0.92 PARP10 (0.70) SRD5A2LTA4HCES2CES1PARP10
SCHEMBL14407949 0.92 PARP10 (0.70) SRD5A2LTA4HCES2CES1PARP10
SCHEMBL17469590 0.92 PARP10 (0.70) SRD5A2LTA4HCES2CES1PARP10
SCHEMBL17469591 0.92 PARP10 (0.70) SRD5A2LTA4HCES2CES1PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4692072-A1 PHOTOCHROMIC COMPOUND, PROPARGYL ALCOHOL COMPOUND, CURABLE COMPOSITION, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2026-02-11 — — EP disclosed
WO-2025070122-A1 PHOTOCHROMIC COMPOSITION, CURABLE COMPOSITION, OPTICAL ARTICLE, LENS, AND EYEGLASSES 株式会社トクヤマ 2025-04-03 — — WO disclosed
WO-2024202087-A1 PHOTOCHROMIC COMPOUND, PROPARGYL ALCOHOL COMPOUND, CURABLE COMPOSITION, OPTICAL ARTICLE, LENS, AND SPECTACLES 株式会社トクヤマ 2024-10-03 — — WO disclosed
US-20240043626-A1 METHOD FOR THE SELECTIVE CLEAVAGE OF A COMPOUND COMPRISING AN AROMATIC RING AND A C-O-C LINKAGE RHODIA OPERATIONS (FR) 2024-02-08 — — US disclosed
EP-4259596-A1 METHOD FOR SELECTIVE CLEAVAGE OF COMPOUND COMPRISING AROMATIC RING AND C-O-C LINKAGE SPECIALTY OPERATIONS FRANCE (FR) 2023-10-18 — — EP disclosed
CN-116648443-A Method for selectively cleaving a compound comprising an aromatic ring and a C-O-C linkage 罗地亚经营管理公司 2023-08-25 — — CN disclosed
WO-2022126310-A1 METHOD FOR SELECTIVE CLEAVAGE OF COMPOUND COMPRISING AROMATIC RING AND C-O-C LINKAGE RHODIA OPERATIONS (FR) 2022-06-23 — — WO disclosed
WO-2022126310-A1 METHOD FOR SELECTIVE CLEAVAGE OF COMPOUND COMPRISING AROMATIC RING AND C-O-C LINKAGE RHODIA OPERATIONS (FR) 2022-06-23 — — WO disclosed
EP-3237493-B1 PAEK/PPSU/PES COMPOSITIONS SOLVAY SPECIALTY POLYMERS USA (US) 2020-04-29 — — EP disclosed
US-20100144955-A1 Thermoplastic polymer mixtures, and applications thereof SOLVAY ADVANCED POLYMERS, L.L.C. (US) 2010-06-10 — — US disclosed
US-20100144955-A1 Thermoplastic polymer mixtures, and applications thereof SOLVAY ADVANCED POLYMERS, L.L.C. (US) 2010-06-10 — — US disclosed
EP-0455332-B1 Acylation or sulphonylation of aromatic compounds ZENECA LTD (GB) 1996-02-21 — — EP disclosed
US-5164527-A Zeolite catalysts IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-11-17 — — US disclosed
EP-0455332-A2 Acylation or sulphonylation of aromatic compounds ZENECA LIMITED (GB) 1991-11-06 — — EP disclosed
US-4794155-A Process for forming arylether polymers THE DOW CHEMICAL COMPANY (US) 1988-12-27 — — US disclosed
US-4115413-A ACID FREE BAYER AKTIENGESELLSCHAFT (DE) 1978-09-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240043626-A1 METHOD FOR THE SELECTIVE CLEAVAGE OF A COMPOUND COMPRISING AN AROMATIC RING AND A C-O-C LINKAGE AOC2, AOC1, AOC3 SRD5A2 1785/4885LTA4H 3765/4885CES2 213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback